As the demand for cannabis analysis grows researchers search for safer, greener solvents that are less damaging to human health and the environment.
Scientists, medical professionals, and consumers alike all stand to benefit from fully characterizing the chemical composition of cannabis.
A 2017 study on the chemistry of dabbing marijuana revealed potential side effects which may be a cause for concern given the popularity of this method of consumption.
As the industry develops there comes a need to consistently produce and test for certain characteristics, like cannabinoid and terpene profiles, in order to achieve the desired results.
Epidiolex contains cannabidiol (CBD) and is the first FDA-approved drug that contains a purified drug substance derived from marijuana.
Lab analysis reveals how even well-known cannabis edibles brands are claiming vastly higher potencies than they are delivering in practice.
Dosing and labeling are currently big issues for cannabis consumers and these results could help improve the quality and consistency of cannabis extracts.
This first-of-its-kind process enables the company to produce cGMP-compliant, pure THC molecules to be used as the active pharmaceutical ingredient in products currently undergoing research for multiple conditions.
Researchers are striving to develop a full-profile, non-psychoactive cannabis extract product to help meet unmet medical needs.